Eric Compton, a rising industry executive is set to take the helm at the hemostatic device-maker Z-Medica. He follows in the footsteps of President and CEO Stephen Fanning.
Connecticut-based hemorrhage control device-maker Z-Medica LLC, has picked Eric Compton to lead the company as its new president and CEO. The former Hologic executive steps in at a time when the company says it is expanding its domestic and international sales operations.
Compton succeeds Stephen Fanning, who served as president and CEO since April 2014. Z-Medica says Fanning is moving back to...
Bivacor aims to be first to the US market with a permanent total artificial heart, starting with use as a bridge to transplant. CMO William Cohn says data from countries with low transplant rates could support pivotal trials and long-term use.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.
Researchers at Johns Hopkins have used a robotic system to autonomously perform a key part of gallbladder surgery without a surgeon's hand. Lead author Axel Krieger says it could take five to 10 years before an autonomous robotic system will reach human trials and expects regulatory hurdles.
The European Commission is focusing on how tiny particles behave to help create an EU industrial “powerhouse.”
Under the terms of the new agreement, Philips will also begin bundling essential supplies – including ECG, noninvasive blood pressure (NIBP) components, and batteries – with its Medtronic-enabled monitors.
Bivacor aims to be first to the US market with a permanent total artificial heart, starting with use as a bridge to transplant. CMO William Cohn says data from countries with low transplant rates could support pivotal trials and long-term use.
